Table 3:

Overall recanalization rates per treatment protocol

StudyNo RecanalizationPartial RecanalizationComplete Recanalization
Study 1 (IA reteplase and MDT), n = 476 (13%)27 (57%)14 (30%)
Study 2 (EKOS), n = 12a1 (10%)*4 (40%)*5 (50%)*
Study 3 (IV thrombolysis and MDT) n = 196 (32%)8 (42%)5 (26%)
Study 4 (IV abciximab and IA reteplase) n = 136 (46%)2 (15%)5 (39%)
  • * Data were missing for 2 patients; percentages are of 10 patients.